Tenax Therapeutics Ownership | Who Owns Tenax Therapeutics?


OverviewRevenueFinancialsChart

Tenax Therapeutics Ownership Summary


Tenax Therapeutics is owned by 11.93% institutional investors, 0.15% insiders, and 87.92% retail investors. Ikarian capital is the largest institutional shareholder, holding 2.45% of TENX shares. TD Health Sciences - I is the top mutual fund, with 4.47% of its assets in Tenax Therapeutics shares.

TENX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTenax Therapeutics11.93%0.15%87.92%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ikarian capital967.60K2.45%$7.36M
Vr adviser437.71K1.11%$3.33M
Rtw investments, lp378.35K0.96%$2.88M
Siren352.44K0.89%$2.68M
Boothbay fund management352.21K0.89%$2.68M
Bvf inc/il339.55K0.86%$2.58M
Vivo capital208.33K0.53%$1.59M
Morgan stanley178.33K0.45%$1.36M
Marshall wace, llp177.21K0.45%$1.35M
Integral health asset management167.00K0.42%$1.27M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital967.60K0.74%$7.36M
Velan capital investment management lp83.33K0.60%$634.16K
Vr adviser437.71K0.19%$3.33M
Vivo capital208.33K0.13%$1.59M
Siren352.44K0.10%$2.68M
Bvf inc/il339.55K0.10%$2.58M
Integral health asset management167.00K0.09%$1.27M
Boothbay fund management352.21K0.04%$2.68M
Adar1 capital management53.43K0.04%$406.59K
Rtw investments, lp378.35K0.04%$2.88M

Top Buyers

HolderShares% AssetsChange
Ikarian capital967.60K0.74%967.60K
Siren352.44K0.10%352.44K
Boothbay fund management352.21K0.04%352.21K
Vr adviser437.71K0.19%339.14K
Marshall wace, llp177.21K0.00%177.21K

Top Sellers

HolderShares% AssetsChange
Adar1 capital management53.43K0.04%-102.13K
Dimensional fund advisors lp---15.93K
Raymond james financial---1.50K
Tower research capital llc (trc)501.000.00%-748.00
Rtw investments, lp378.35K0.04%-

New Positions

HolderShares% AssetsChangeValue
Ikarian capital967.60K0.74%967.60K$7.36M
Siren352.44K0.10%352.44K$2.68M
Boothbay fund management352.21K0.04%352.21K$2.68M
Marshall wace, llp177.21K0.00%177.21K$1.35M
Woodline partners lp88.21K0.00%88.21K$671.29K

Sold Out

HolderChange
Raymond james financial-1.50K
Dimensional fund advisors lp-15.93K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20253332.00%4,720,737111.51%1137.50%20150.00%2-50.00%
Jun 30, 2025258.70%2,231,96111.24%518.75%8-11.11%433.33%
Mar 31, 2025239.52%2,006,42247.29%56.89%9-3-
Dec 31, 20242110.53%1,362,19010.84%826.45%9-43.75%3200.00%
Sep 30, 20241990.00%1,228,9206426.74%573334.16%16220.00%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
TD Health Sciences - I177.30K4.47%-
Vanguard Total Stock Mkt Idx Inv96.16K2.32%96.16K
T. Rowe Price Health Sciences21.18K0.62%-89.13K
Vanguard Institutional Extnd Mkt Idx Tr24.09K0.58%1.80K
Fidelity Extended Market Index17.93K0.39%-147.00
DFA US Targeted Value I13.39K0.29%-
T. Rowe Price Health Sciences Port5.36K0.16%5.36K
Fidelity Total Market Index5.97K0.13%-
NT Ext Equity Mkt Idx Fd - NL4.59K0.11%-
Fidelity Series Total Market Index4.86K0.11%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 18, 2025Giordano Christopher Thomas CEOBuy$12.50K
Nov 20, 2025Giordano Christopher Thomas CEOBuy$4.08K
Nov 19, 2025Giordano Christopher Thomas CEOBuy$3.42K
Nov 17, 2025MCGAULEY THOMAS Interim CFOBuy$14.67K
Nov 17, 2025MCGAULEY THOMAS Interim CFOBuy$36.14K

Insider Transactions Trends


DateBuySell
2025 Q48-
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--

TENX Ownership FAQ


Who Owns Tenax Therapeutics?

Tenax Therapeutics shareholders are primarily institutional investors at 11.93%, followed by 0.15% insiders and 87.92% retail investors. The average institutional ownership in Tenax Therapeutics's industry, Biotech Stocks , is 45.24%, which Tenax Therapeutics falls below.

Who owns the most shares of Tenax Therapeutics?

Tenax Therapeutics’s largest shareholders are Ikarian capital (967.6K shares, 2.45%), Vr adviser (437.71K shares, 1.11%), and Rtw investments, lp (378.35K shares, 0.96%). Together, they hold 4.51% of Tenax Therapeutics’s total shares outstanding.

Does Blackrock own Tenax Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tenax Therapeutics.

Who is Tenax Therapeutics’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Tenax Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.74% of its assets in 967.6K Tenax Therapeutics shares, valued at 7.36M$.

Who is the top mutual fund holder of Tenax Therapeutics shares?

TD Health Sciences - I is the top mutual fund holder of Tenax Therapeutics shares, with 4.47% of its total shares outstanding invested in 177.3K Tenax Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools